The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Interesting you should mention boohoo, everytime I think about boohoo I think about burford..
You see I've been in and out of both and they ain't without fear a d issues of their own making!!!
Each to their own and always but always do your own research...
Nice time to top up, im grateful for the seller tbh. Hoping this stays here until the end of March when the bonus comes in...having said that I might be too late...
The potential upside is so strong that it's worth the wait. When the Japanese deal comes in (and imo it will) we are looking at a £200m mkt cap.
That will be. Beauty to behold...
Barely any volume to make strides so no concerns about sellers etc.
Waiting patiently for news and my holding has only increased in the last 3 months!
Just checking everybody is still holding lol, unusually quiet over the past few days, calm before the storm, was hoping for the usual share pattern of rise in anticipation of news , given the deadline, i suppose the constant seller is putting a stop to that
Little top up
worth noting that a similar rise in mcap for NFX would take us to between 18-19p. I do think however there is potential for NFX to become a unicorn in future, if the company plays its card rights and we have no more repeats of the fiasco's of late.
Agree with Soup here....think the fact we have patents and pending patents on PROVEN tech this is a very good investment. NCYT are riding a wave. I have read myself Cocrystal tech has shown to help with influenza/viruses in studies. Even the link below from years ago shows promise. With NFX I believe we are ahead of the game. When the deals follow, we will know how big.
https://jvi.asm.org/content/82/5/2515
Forget the in lol, we could also include Exxon lol
BP and Shell could crash, they both have , and gone back up, surely you can’t relate these two shares to NFX. In
Soup. Agree. NFX has greater long term value imho. Ncyt could crash back anytime and very volatile.
Some people done very well from ncyt but others lost out big time. I personally have been watching but some of the posters are frankly hoping the pandemic happens to make money from it. Doesn't sit right with me. Lots of grandstanding as though they are supporting the fight against coronavirus when in fact they aren't supporting the testing or vaccine development at all. Genuine investors already in before the virus hit have helped the company, not just themselves. All my opinion and apologies if a bit soapboxy.
Arc, NFX has greater potential. NCYT is valued at £100m which is fair given the quantities they are likely to sell. Its good to ride the wave of the trade over there.
NCYT product is limited, it isn't patented and once a quicker accurate test comes available then its market lead disappears (Qiagen already have a 1 hour test which beats NCYT but has to run on Qiagen equipment), whereas NFX has a patent and can secure market share so that others cannot do the same. Hence it has greater long term value.
Ncyt has got caught in a world diaster, the share holders have done well .
I think here it's steady as you go ,
BP and shell are built on oil which could crash one day ,the world's changing and you just have to be the right place at the right time time , hopefully we are with nfx .
How many shareholders here think that NFX has the capability to rise to the levels we are currently seeing in NCYT. Once we get positive news flow with ref to NXP002 & NXP004 along with the payments due from China for NXP001, rest of world rights & also Ebers with the cannabinoids I personally see a big re-rate for these shares.
Please DYOR.